Subconjunctival Bevacizumab Injection in Glaucoma Filtering Surgery: A Case Control Series

Table 3

Mean IOP in the subconjunctival bevacizumab (SCB) and control groups during the follow-up period.

	SCB group; 𝑁=30	Control group; 𝑁=30	𝑃 value
IOP 1 month; (mmHg)	14.4 ± 4.7	12.8 ± 4.8	0.83
IOP 3 months; (mmHg)	11.8 ± 4.6	12.8 ± 5.0	0.44
IOP 6 months; (mmHg)	11.5 ± 3.7	12.5 ± 4.3	0.42
IOP 1 year; (mmHg)	13.8 ± 3.6	13.2 ± 4.9	0.30
IOP final visit; (mmHg)	14.0 ± 4.7	11.9 ± 4.7	0.36